CLINICAL_TRIALS trial_result · 2023-02-15

Clinical Trial Update: Denosumab for Smoldering Multiple Myeloma [Phase 2]

Phase 2 clinical trial of denosumab in smoldering multiple myeloma has completed and results were posted in February 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Rochester | Conditions: Smoldering Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2023-02-15